The invention relates to the use of a compound acting as mGluR5 antagonist inthe treatment, preventions and/ordelay of progression of disorders of the gastro-intestinal tract, disorders ofthe urinary tract and/or post-operative disorders and tothe treatment, prevention and/or delay of progression of pain associated withthese indications.